Home HIV FAQ My Amedeo About Flying Publisher   

Amedeo Prize 2008
The 21 Finalists


  Vaccines

  Free Subscription


Articles published in AIDS Res Hum Retroviruses

Retrieve available abstracts of 16 articles:
HTML format



Single Articles


    March 2008
  1. DUDANI AK , Martyres A, Fliss H
    Rapid Preparation of Preventive and Therapeutic Whole-Killed Retroviral Vaccines Using the Microbicide Taurine Chloramine.
    AIDS Res Hum Retroviruses. 2008;.
    PubMed     Related articles    Abstract available


  2. MANRIQUE M , Micewicz E, Kozlowski PA, Wang SW, et al
    DNA-MVA Vaccine Protection after X4 SHIV Challenge in Macaques Correlates with Day-of-Challenge Antiviral CD4(+) Cell-Mediated Immunity Levels and Postchallenge Preservation of CD4(+) T Cell Memory.
    AIDS Res Hum Retroviruses. 2008;24:505-19.
    PubMed     Related articles    Abstract available


    February 2008
  3. SHEPHARD E , Burgers WA, van Harmelen JH, Monroe JE, et al
    A Multigene HIV Type 1 Subtype C Modified Vaccinia Ankara (MVA) Vaccine Efficiently Boosts Immune Responses to a DNA Vaccine in Mice.
    AIDS Res Hum Retroviruses. 2008;.
    PubMed     Related articles    Abstract available


  4. BURGERS WA , Shephard E, Monroe JE, Greenhalgh T, et al
    Construction, Characterization, and Immunogenicity of a Multigene Modified Vaccinia Ankara (MVA) Vaccine Based on HIV Type 1 Subtype C.
    AIDS Res Hum Retroviruses. 2008;.
    PubMed     Related articles    Abstract available


    December 2007
  5. ROBINSON HL , Sharma S, Zhao J, Kannanganat S, et al
    Immunogenicity in Macaques of the Clinical Product for a Clade B DNA/MVA HIV Vaccine: Elicitation of IFN-gamma, IL-2, and TNF-alpha Coproducing CD4 and CD8 T Cells.
    AIDS Res Hum Retroviruses. 2007;23:1555-62.
    PubMed     Related articles    Abstract available


    November 2007
  6. ANDRESEN BS , Vinner L, Tang S, Bragstad K, et al
    Characterization of Near Full-Length Genomes of HIV Type 1 Strains in Denmark: Basis for a Universal Therapeutic Vaccine.
    AIDS Res Hum Retroviruses. 2007;23:1442-8.
    PubMed     Related articles    Abstract available


  7. GACH JS , Quendler H, Weik R, Katinger H, et al
    Partial Humanization and Characterization of an Anti-idiotypic Antibody against Monoclonal Antibody 2F5, a Potential HIV Vaccine?
    AIDS Res Hum Retroviruses. 2007;23:1405-15.
    PubMed     Related articles    Abstract available


  8. LIU L , Wan Y, Xu J, Huang X, et al
    Immunogenicity Comparison between Codon Optimized HIV-1 CRF BC_07 gp140 and gp145 Vaccines.
    AIDS Res Hum Retroviruses. 2007;23:1396-1404.
    PubMed     Related articles    Abstract available


  9. WILKINSON RA , Evans JR, Jacobs JM, Slunaker D, et al
    Peptides Selected from a Phage Display Library with an HIV-Neutralizing Antibody Elicit Antibodies to HIV gp120 in Rabbits, But Not to the Same Epitope.
    AIDS Res Hum Retroviruses. 2007;23:1416-27.
    PubMed     Related articles    Abstract available


    October 2007
  10. FINNEFROCK AC , Liu X, Opalka DW, Shiver JW, et al
    HIV Type 1 Vaccines for Worldwide Use: Predicting In-Clade and Cross-Clade Breadth of Immune Responses.
    AIDS Res Hum Retroviruses. 2007;23:1283-1292.
    PubMed     Related articles    Abstract available


    September 2007
  11. GOUJARD C , Marcellin F, Hendel-Chavez H, Burgard M, et al
    Interruption of Antiretroviral Therapy Initiated during Primary HIV-1 Infection: Impact of a Therapeutic Vaccination Strategy Combined with Interleukin (IL)-2 Compared with IL-2 Alone in the ANRS 095 Randomized Study.
    AIDS Res Hum Retroviruses. 2007;23:1105-13.
    PubMed     Related articles    Abstract available


    July 2007
  12. IM EJ , Hanke T
    Short Communication: Preclinical Evaluation of Candidate HIV Type 1 Vaccines in Inbred Strains and an Outbred Stock of Mice.
    AIDS Res Hum Retroviruses. 2007;23:857-62.
    PubMed     Related articles    Abstract available


    June 2007
  13. COSMA A , Nagaraj R, Staib C, Diemer C, et al
    Evaluation of Modified Vaccinia Virus Ankara as an Alternative Vaccine against Smallpox in Chronically HIV Type 1-Infected Individuals Undergoing HAART.
    AIDS Res Hum Retroviruses. 2007;23:782-793.
    PubMed     Related articles    Abstract available


    May 2007
  14. CUMMINS JE JR , Denniston M, Mayer KH, Pickard R, et al
    Mucosal Innate Immune Factors in Secretions from High-Risk Individuals Immunized with a Bivalent gp120 Vaccine.
    AIDS Res Hum Retroviruses. 2007;23:748-54.
    PubMed     Related articles    Abstract available


    April 2007
  15. RUTEBEMBERWA A , Bess JW Jr, Brown B, Arroyo M, et al
    Evaluation of Aldrithiol-2-Inactivated Preparations of HIV Type 1 Subtypes A, B, and D as Reagents to Monitor T Cell Responses.
    AIDS Res Hum Retroviruses. 2007;23:532-42.
    PubMed     Related articles    Abstract available


    March 2007
  16. GAHERY H , Figueiredo S, Texier C, Pouvelle-Moratille S, et al
    HLA-DR-Restricted Peptides Identified in The Nef Protein Can Induce HIV Type 1-Specific IL-2/IFN-gamma-Secreting CD4(+) And CD4(+) /CD8(+) T Cells in Humans after Lipopeptide Vaccination.
    AIDS Res Hum Retroviruses. 2007;23:427-37.
    PubMed     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Bernd Sebastian Kamps website.

   Design: